ECG Amplitude Spectrum Analysis for Cardiac Viability Assessment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical devices for cardiac arrhythmia management, such as defibrillation and pacing, often face delays in treatment due to the need for manual intervention and lack of real-time analysis of cardiac viability, which can reduce the effectiveness of interventions like CPR and defibrillation in cardiac arrest situations.
Innovation Solution
A non-invasive ambulatory medical monitoring and treatment device that uses electrocardiogram (ECG) signal analysis, specifically spectral analysis of the amplitude spectrum of ventricular fibrillation waveforms, to determine the viability of the heart and the likelihood of successful therapeutic interventions, thereby accelerating or delaying the application of electrical therapy like defibrillation and recommending alternative treatments like CPR.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Loss of time
If manual intervention and traditional ECG analysis are used for cardiac arrhythmia management, then device complexity is reduced, but treatment delay increases and effectiveness decreases
Solution Approach 1:
The device performs preliminary analysis of cardiac viability using spectral analysis of ECG signals before delivering defibrillation therapy. This allows the system to assess whether the heart is likely to respond to therapy in advance, enabling more timely and effective treatment decisions without requiring manual intervention during the critical moment of therapy delivery.
Solution Approach 2:
The device creates a spectral representation (amplitude spectrum) of the ECG signal as a copy or transformed version of the original signal. This spectral copy allows for automated analysis of cardiac viability features without requiring manual interpretation of the raw ECG waveform, thereby reducing treatment delay while maintaining analytical accuracy.
2Reliability
If real-time spectral analysis of ECG signals is performed to assess cardiac viability, then treatment effectiveness is improved, but measurement precision requirements increase
Solution Approach 1:
The device transforms the ECG signal from the time domain to the frequency domain using spectral analysis. This dimensional transformation allows the system to assess cardiac viability based on frequency distribution characteristics (amplitude spectrum) rather than time-domain waveform morphology, providing more reliable and objective measures of cardiac responsiveness to therapy.
Solution Approach 2:
The system changes the parameters used for viability assessment from traditional time-domain ECG features to frequency-domain spectral features. By analyzing the amplitude spectrum and identifying specific frequency characteristics, the device achieves more precise and reliable measurement of cardiac viability, directly improving treatment effectiveness.
3Productivity
If automated real-time ECG analysis with spectral transformation is implemented, then productivity of treatment delivery is improved, but device complexity increases
Solution Approach 1:
The device performs automated self-assessment of cardiac viability through spectral analysis of ECG signals. The system independently determines whether the heart is likely to respond to defibrillation therapy without requiring external manual evaluation, enabling faster automated treatment decisions and improving productivity in life-saving interventions.
Solution Approach 2:
The device replaces manual mechanical assessment (physician evaluation of ECG signals) with automated electronic spectral analysis. The processor automatically transforms ECG signals into frequency domain representations and interprets viability characteristics, substituting human expertise with electronic signal processing to accelerate treatment delivery.
Data Source
AI summary
A medical monitoring and treatment device that includes a therapy delivery interface, a plurality of therapy electrodes coupled to the therapy delivery interface, a plurality of electrocardiogram sensing electrodes to sense electrocardiogram signals of a patient, a sensor interface to receive the electrocardiogram signals and digitize the electrocardiogram signals, and at least one processor coupled to the sensor interface and the therapy delivery interface to analyze the digitized electrocardiogram signals, to detect a cardiac arrhythmia based on the digitized electrocardiogram signals, and to control the therapy delivery interface to apply electrical therapy to the patient based upon the detected cardiac arrhythmia. The at least one processor is further configured to analyze a frequency domain transform of the digitized electrocardiogram signals, to determine a metric indicative of a metabolic state of a heart of the patient, and to accelerate or delay application of the electrical therapy based upon the metric.